BALDUCCI, Anna Giulia
 Distribuzione geografica
Continente #
EU - Europa 813
NA - Nord America 811
AS - Asia 422
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.053
Nazione #
US - Stati Uniti d'America 804
CN - Cina 305
IE - Irlanda 224
SE - Svezia 173
FI - Finlandia 164
IT - Italia 79
DE - Germania 75
TR - Turchia 49
SG - Singapore 36
UA - Ucraina 28
FR - Francia 25
IN - India 21
GB - Regno Unito 13
CZ - Repubblica Ceca 10
BE - Belgio 7
CA - Canada 7
ES - Italia 7
JP - Giappone 6
AT - Austria 4
MY - Malesia 3
NL - Olanda 3
AU - Australia 1
BR - Brasile 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
KR - Corea 1
ZA - Sudafrica 1
Totale 2.053
Città #
Dublin 224
Chandler 197
Dearborn 84
Ashburn 59
Beijing 52
Jacksonville 52
Izmir 49
Nanjing 49
Princeton 38
Parma 33
Shanghai 33
Wilmington 32
Bremen 27
Singapore 19
Ann Arbor 16
Helsinki 16
Nanchang 15
Hebei 14
Pune 14
Milan 13
Hefei 12
San Mateo 12
Kunming 11
Brno 10
Jiaxing 10
Shenyang 10
Changsha 8
Los Angeles 8
Guangzhou 7
Santiago De Compostela 7
Tianjin 7
Falls Church 6
Jinan 6
London 6
New York 6
Norwalk 6
Boardman 5
Brussels 5
Toronto 5
Formigine 4
Fuzhou 4
Philadelphia 4
Southend 4
Vienna 4
Chennai 3
Düsseldorf 3
Munich 3
Pioltello 3
Seattle 3
Taizhou 3
Zhengzhou 3
Chicago 2
Des Moines 2
Fremont 2
Gopeng 2
Grafing 2
Houston 2
Krempermoor 2
Mestre 2
Montefiore dell'Aso 2
Ningbo 2
Osaka 2
Rockville 2
Simi Valley 2
Wenzhou 2
Abidjan 1
Alghero 1
Amsterdam 1
Bielefeld 1
Borås 1
Castenaso 1
Chengdu 1
Chongqing 1
Cyberjaya 1
Dalian 1
Fayetteville 1
Florence 1
Geislingen an der Steige 1
Godhra 1
Hangzhou 1
Islington 1
Johannesburg 1
Liège 1
Luton 1
Melbourne 1
Montréal 1
Mountain View 1
North Bergen 1
Padova 1
Plesnoy 1
Puxian 1
Saronno 1
Sault Ste. Marie 1
Scottsdale 1
Selargius 1
Shaoxing 1
Shenzhen 1
Szeged 1
São Paulo 1
Taiyuan 1
Totale 1.287
Nome #
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 97
Solid-state characterization of tobramycin powders for inhalation 94
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 71
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 70
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers 70
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 69
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 69
Brain distribution of ribavirin after intranasal administration 67
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation 67
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate 65
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 64
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 62
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 61
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 59
Layered lipid microcapsules for mesalazine delayed-release in children 57
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 57
Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers 57
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 55
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 55
Performance of Different Nebulizers in the Aerosolization of Colistimethate Sodium 53
Soft agglomerates of mesalazine multiparticles for colonic delivery in pediatric patients 52
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 52
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 52
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 51
Influence of Sodium Stearate on Amikacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis Patients with Pseudomonas Aeruginosa Lung Infections 51
Liposome sensing and monitoring by organic electrochemical transistors integrated in microfluidics 49
Dry Coating Technique for Inhalation Powders 49
The Influence of Energy Input During Dry Powder Blending on Dynamic Flow Properties, Powder Aerosolization and Dissolution of Dry Powders for Inhalation 49
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the in Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler 48
Treatment of equine sarcoids 47
Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients 46
Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds 46
PREPARATION OF SOFT AGGLOMERATES BASED ON ARTEMISININ-βCD COMPLEXES 43
Drug Delivery Strategies for Pulmonary Administration of Antibiotics 41
PURE INSULIN HIGHLY RESPIRABLE POWDERS FOR INHALATION 41
Polymeric Films Loaded with Vitamin E and Aloe vera for Topical Application in the Treatment of Burn Wounds 36
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment—A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 30
Patent Foramen Ovale Related Cryptogenic Stroke during COVID-19 Disease in Three Patients: A Case Series 28
Totale 2.130
Categoria #
all - tutte 7.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020393 91 71 16 5 19 70 49 7 12 30 10 13
2020/202187 0 8 5 3 15 1 8 1 33 1 11 1
2021/2022135 2 2 0 2 4 6 12 15 9 10 4 69
2022/2023762 67 109 45 49 65 75 1 57 269 1 24 0
2023/2024266 16 33 6 8 20 58 28 11 3 15 25 43
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 2.130